Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians

被引:94
作者
Betts, MR
Krowka, J
Santamaria, C
Balsamo, K
Gao, F
Mulundu, G
Luo, CW
NGandu, N
Sheppard, H
Hahn, BH
Allen, S
Frelinger, JA
机构
[1] UNIV N CAROLINA,DEPT MICROBIOL & IMMUNOL,CHAPEL HILL,NC 27599
[2] CALIF DEPT HLTH SERV,VIRAL & RICKETTSIAL DIS LAB,DIV COMMUNICABLE DIS CONTROL,BERKELEY,CA 94704
[3] UNIV ALABAMA,SCH PUBL HLTH,DEPT MED,BIRMINGHAM,AL 35294
[4] UNIV ALABAMA,SCH PUBL HLTH,DEPT EPIDEMIOL,BIRMINGHAM,AL 35294
[5] UNIV TEACHING HOSP,DEPT LAB MED,LUSAKA,ZAMBIA
[6] UNIV TEACHING HOSP,DEPT PEDIAT,LUSAKA,ZAMBIA
[7] UNIV TEACHING HOSP,DEPT COMMUNITY MED,LUSAKA,ZAMBIA
关键词
D O I
10.1128/JVI.71.11.8908-8911.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have examined cross-clade HIV-specific cytotoxic T-lymphocyte (CTL) activity in peripheral blood of eight Zambian individuals infected with non-B-clade human immunodeficiency virus type 1 (HIV-1). Heteroduplex mobility assay and partial sequence analysis of env and gag genes strongly suggests that all the HIV-infected subjects were infected with clade C HIV-1. Six of eight C-clade HN-infected individuals elicited CTL activity specific for recombinant vaccinia virus-infected autologous targets expressing HIV gag-pol-env derived from B-clade HIV-1 (IIIB). Recognition of individual recombinant HIV-1 B-clade vaccinia virus-infected targets expressing gag, pol, or env was variable among the patients tested, indicating that cross-clade CTL activity is not limited to a single HIV protein. These data demonstrate that HIV clade C-infected individuals can mount vigorous HIV clade B-reactive CTL responses.
引用
收藏
页码:8908 / 8911
页数:4
相关论文
共 29 条
  • [21] Genetic, antigenic and serologic characterization of human immunodeficiency virus type 1 from Indonesia
    Porter, KR
    Mascola, JR
    Hupudio, H
    Ewing, D
    VanCott, TC
    Anthony, RL
    Corwin, AL
    Widodo, S
    Ertono, S
    McCutchan, FE
    Burke, DS
    Hayes, CG
    Wignall, FS
    Graham, RR
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (01): : 1 - 6
  • [22] RECOMBINATION IN AIDS VIRUSES
    ROBERTSON, DL
    HAHN, BH
    SHARP, PM
    [J]. JOURNAL OF MOLECULAR EVOLUTION, 1995, 40 (03) : 249 - 259
  • [23] THE NEIGHBOR-JOINING METHOD - A NEW METHOD FOR RECONSTRUCTING PHYLOGENETIC TREES
    SAITOU, N
    NEI, M
    [J]. MOLECULAR BIOLOGY AND EVOLUTION, 1987, 4 (04) : 406 - 425
  • [24] Full-length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C
    Salminen, MO
    Johansson, B
    Sonnerborg, A
    Ayehunie, S
    Gotte, D
    Leinikki, P
    Burke, DS
    McCutchan, FE
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (14) : 1329 - 1339
  • [25] SETTE A, 1994, J IMMUNOL, V153, P5586
  • [26] CROSS-CLADE NEUTRALIZATION OF PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY HUMAN MONOCLONAL-ANTIBODIES AND TETRAMERIC CD4-IGG
    TRKOLA, A
    POMALES, AB
    YUAN, H
    KORBER, B
    MADDON, PJ
    ALLAWAY, GP
    KATINGER, H
    BARBAS, CF
    BURTON, DR
    HO, DD
    MOORE, JP
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (11) : 6609 - 6617
  • [27] Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
    Trkola, A
    Purtscher, M
    Muster, T
    Ballaun, C
    Buchacher, A
    Sullivan, N
    Srinivasan, K
    Sodroski, J
    Moore, JP
    Katinger, H
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (02) : 1100 - 1108
  • [28] TSUJI K, 1991, P 11 HIST WORKSH C H, V1
  • [29] Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: Effects of viral variation on cytotoxic T-lymphocyte recognition
    Wilson, CC
    Kalams, SA
    Wilkes, BM
    Ruhl, DJ
    Gao, F
    Hahn, BH
    Hanson, IC
    Luzuriaga, K
    Wolinsky, S
    Koup, R
    Buchbinder, SP
    Johnson, RP
    Walker, BD
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (02) : 1256 - 1264